Human Genome Epidemiology Literature Finder
|
Records 1 - 4 (of 4 Records) |
| Query Trace: Multiple Sclerosis and IL22RA2[original query] |
|---|
| A cytokine gene screen uncovers SOCS1 as genetic risk factor for multiple sclerosis. Genes and immunity 2012 Jan 13 (1): 21-8. Vandenbroeck K, Alvarez J, Swaminathan B, Alloza I, Matesanz F, Urcelay E, Comabella M, Alcina A, Fedetz M, Ortiz M A, Izquierdo G, Fernandez O, Rodriguez-Ezpeleta N, Matute C, Caillier S, Arroyo R, Montalban X, Oksenberg J R, Antigüedad A, Aransay |
| Assessment of microRNA-related SNP effects in the 3' untranslated region of the IL22RA2 risk locus in multiple sclerosis. Neurogenetics 2014 May 15 (2): 129-34. Lill Christina M, Schilling Marcel, Ansaloni Sara, Schröder Julia, Jaedicke Marian, Luessi Felix, Schjeide Brit-Maren M, Mashychev Andriy, Graetz Christiane, Akkad Denis A, Gerdes Lisa-Ann, Kroner Antje, Blaschke Paul, Hoffjan Sabine, Winkelmann Alexander, Dörner Thomas, Rieckmann Peter, Steinhagen-Thiessen Elisabeth, Lindenberger Ulman, Chan Andrew, Hartung Hans-Peter, Aktas Orhan, Lohse Peter, Buttmann Mathias, Kümpfel Tania, Kubisch Christian, Zettl Uwe K, Epplen Joerg T, Zipp Frauke, Bertram La |
| Pharmacogenetics of glatiramer acetate therapy for multiple sclerosis: the impact of genome-wide association studies identified disease risk loci. Pharmacogenomics 2017 Nov . Kulakova Olga, Bashinskaya Vitalina, Kiselev Ivan, Baulina Natalia, Tsareva Ekaterina, Nikolaev Ruslan, Kozin Maxim, Shchur Sergey, Favorov Alexander, Boyko Alexey, Favorova Ol |
| Influence of Genetic Polymorphisms on Clinical Outcomes of Glatiramer Acetate in Multiple Sclerosis Patients. Journal of personalized medicine 2021 Oct 11 (10): . Zarzuelo-Romero María José, Pérez-Ramírez Cristina, Cura Yasmín, Carrasco-Campos María Isabel, Marangoni-Iglecias Luciana María, Ramírez-Tortosa María Carmen, Jiménez-Morales Alber |
- Page last reviewed:Feb 1, 2024
- Content source: